Cambridge Healthtech Institute’s 4th Annual

Diagnostics Market Access

Reimbursement and Market Access Strategies for Advanced Diagnostics

March 12-13, 2025

The COVID-19 pandemic has fueled explosive innovation, investment, and market opportunities for advanced diagnostics. Cambridge Healthtech Institute’s 4th Annual Diagnostics Market Access conference will highlight investment, regulatory, reimbursement, and market access strategies for advanced diagnostics and precision medicine in the post-pandemic era.

Coverage will include, but is not limited to:

Regulatory and reimbursement strategies in the post-pandemic era
Market access and partnering strategies for precision medicine and genetic testing
Reimbursement strategies for emerging diagnostics
Collaboration between key stakeholders
Equitable patient access to emerging technologies
Real-world evidence for innovative diagnostics

The deadline for priority consideration is August 16, 2024.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: